Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadonilimab, Fruquintinib, and SBRT in MSS Colorectal Cancer
NCT06168786Phase 2Recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jun 2023
- Primary completion
- Feb 2026
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cadonilimab in colorectal cancer (CRC), sponsored by Huazhong University of Science and Technology. Started Jun 2023; status: recruiting.
02
Drugs
cadonilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06168786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06168786.